Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5537094 | Vaccine | 2017 | 6 Pages |
Abstract
Overall, two fIPV doses are more immunogenic than a single full-dose, associated with significantly increased seroconversion rates and antibody titers. Two fIPV doses together use two-fifth of the vaccine compared to one full-dose IPV. In response to the current IPV shortage, a schedule of two fIPV doses at ages 6 and 14 weeks has been endorsed by technical oversight committees and has been introduced in some affected countries.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Abhijeet Anand, Natalie A. Molodecky, Mark A. Pallansch, Roland W. Sutter,